Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Lixisenatide shaping up to rival Victoza

September 22, 2010 Research and Development Lixisenatide, Sanofi-Aventis, diabetes

Data for Sanofi-Aventis’ injectable lixisenatide suggests it could rival Novo Nordisk’s drug Victoza.Lixisenatide is a once-daily GLP-1 receptor agonist, and …
News

Public sceptical of pharma research

September 21, 2010 Research and Development Animal testing, Animal tests

Businesses including drug companies are seen as broadly untrustworthy or self-serving when it comes to medical research. This is one …
News

Medical, marketing & sales: making cross-functional working work

September 21, 2010 Research and Development, Sales and Marketing marketing, sales force effectiveness, sales representatives

A successful market access strategy requires the close collaboration of all functions within a pharmaceutical company. Most notably, the triumvirate …
Feature

Transition drops new diabetes drug

September 20, 2010 Research and Development Transition Therapeutics, diabetes, lilly

Transition Therapeutics is to abandon trials of its new diabetes treatment TT-223 following disappointing trial results. The Canadian biopharma company …
News

Novartis hails longer-lasting COPD drug

September 20, 2010 Research and Development, Sales and Marketing COPD, Novartis, Onbrez Breezhaler

A phase III treatment for COPD has demonstrated superior results over GSK’s established Serevent (salmeterol). Data from Novartis’ INSIST study …
News
GlaxoSmitKline logo

GSK workers in Ireland await review

September 20, 2010 Manufacturing and Production, Research and Development GlaxoSmithKline, Ireland, job cuts

Workers at a GlaxoSmithKline facility in Ireland are anxiously awaiting the outcome of an official review of the operation amid …
News
Alan_Watt

Cellzome hires GSK’s Alan Watt

September 20, 2010 Research and Development Cellzome, appointment, research and development

Cambridge, UK-based drug discovery and development company Cellzome has appointed Alan Watt to its senior management team as vice president …
Appointment

Contract research news in brief

September 20, 2010 Research and Development Covance, Galapagos, MediData Solutions, MediSync BioServices, PPD, Quotient Bioresearch, i3

A round-up of recent news from the CRO sector, featuring updates from Covance, Quotient Bioresearch, PPD, i3, Galapagos, MediSync BioServices …
News

GSK switches to subcutaneous route for antibody

September 16, 2010 Research and Development Arzerra, Genmab, GlaxoSmithKline, ofatumumab

GlaxoSmithKline says it will switch development of a new antibody treatment to a subcutaneous injection, to make it more commercially …
News

Norgine appoints global quality director

September 16, 2010 Manufacturing and Production, Research and Development Norgine, appointment, manufacturing and production, research and development

Rosemarie Corrigan has joined European specialty pharmaceutical company Norgine as director of global quality, taking a leadership role across a …
Appointment

Gene therapy advance hailed for thalassemia

September 16, 2010 Research and Development Bluebird Bio, gene therapy, thalassemia

A new gene therapy for one of the most frequently inherited genetic disorders has produced promising results. The trial by …
News

Novo expands diabetes research in China

September 16, 2010 Research and Development China, Novo Nordisk, diabetes

Diabetes is at the core of Novo Nordisk’s latest investment in China, where the company plans to more than double …
News

Pepscan and Tibotec sign peptides deal

September 15, 2010 Research and Development, Sales and Marketing CLIPS, HIV, J&J, JJ, Pepscan, Tibotec

Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …
News

Positive results for irritable bowel syndrome drug

September 14, 2010 Research and Development Almirall, IBS, linaclotide

A new treatment for patients with irritable bowel syndrome with constipation has produced promising results in a phase III trial. …
News

Future of Roche diabetes trial uncertain

September 14, 2010 Research and Development GLP-1, Roche, taspoglutide

Roche has admitted it does not know when phase III trials of the investigational type II diabetes drug taspoglutide will …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026